Severe Asthma With An Eosinophilic Phenotype clinical trials

Explore recruiting severe asthma with an eosinophilic phenotype clinical trials.

Also recruiting in Europe

Severe Asthma With An Eosinophilic Phenotype trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A multi-centre, single arm, open-label extension study to evaluate the long-term safety of GSK3511294 (Depemokimab) in adult and adolescent participants with severe asthma with an eosinophilic phenotype from studies 206713 or 213744

Germany, Spain, Poland, Hungary, Czechia, France +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A 52-week, randomised, double-blind, double-dummy, parallel group, multi-centre, non-inferiority study assessing exacerbation rate, additional measures of asthma control and safety in adult and adolescent severe asthmatic participants with an eosinophilic phenotype treated with GSK3511294 (depemokimab) compared with mepolizumab or benralizumab

Slovenia, Netherlands, Portugal, Italy, France, Sweden +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Severe Asthma With An Eosinophilic Phenotype trials by city

Severe Asthma With An Eosinophilic Phenotype in Toronto Severe Asthma With An Eosinophilic Phenotype in Vancouver Severe Asthma With An Eosinophilic Phenotype in Montreal Severe Asthma With An Eosinophilic Phenotype in Calgary Severe Asthma With An Eosinophilic Phenotype in Edmonton Severe Asthma With An Eosinophilic Phenotype in Ottawa Severe Asthma With An Eosinophilic Phenotype in Winnipeg Severe Asthma With An Eosinophilic Phenotype in Quebec City Severe Asthma With An Eosinophilic Phenotype in Hamilton Severe Asthma With An Eosinophilic Phenotype in Kitchener Severe Asthma With An Eosinophilic Phenotype in London Severe Asthma With An Eosinophilic Phenotype in Halifax Severe Asthma With An Eosinophilic Phenotype in New York Severe Asthma With An Eosinophilic Phenotype in Los Angeles Severe Asthma With An Eosinophilic Phenotype in Chicago Severe Asthma With An Eosinophilic Phenotype in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease